| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.70B | +56.7% |
| R&D Expense | $404.1M | +26.0% |
| SG&A Expense | $841.3M | +36.1% |
| Operating Income | -$222.3M | +50.2% |
| Interest Expense | $10.7M | -15.5% |
| Pre-tax Income | -$189.7M | +56.3% |
| Income Tax | $695K | +156.5% |
| Net Income | -$190.4M | +56.2% |
| EPS (Basic) | -$1.53 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $22.7M | -90.4% |
| Accounts Receivable | $314.2M | +12.9% |
| Inventory | $44.7M | +9.8% |
| Current Assets | $1.38B | +9.3% |
| Total Assets | $1.66B | +15.2% |
| Current Liabilities | $344.0M | +12.0% |
| Long-term Debt | $282.9M | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $135.7M | +154.9% |
| Capital Expenditures | $66.4M | +69.5% |
| Investing Cash Flow | $137.6M | -18.3% |
| Financing Cash Flow | $30.2M | -88.1% |
| Free Cash Flow | $69.2M | +124.2% |
| +59.5% |
| EPS (Diluted) | -$1.53 | +59.5% |
| Total Liabilities |
| $465.3M |
| -31.2% |
| Stockholders' Equity | $1.20B | +56.2% |